Friday broker round-up UPDATE
Acal: N+1 Singer initiates with a target price of 380p and a buy recommendation. AstraZeneca: Societe Generale ups target price from 3030p to 3126p, but still recommends selling. Barratt Developments: Deutsche Bank raises target price from 394p to 480p keeping a buy recommendation. Beazley: Canac
Read more